Inventor · disambiguated record
Michael P. Smolinski
Also filed as: SMOLINSKI MICHAEL · SMOLINSKI MICHAEL P
13 granted patents·11 pending applications·326 citations·filing 2002–2024
90Inventor score
Top patents by PatentIndex Score
24 records- 0196US6720935B2Single and dual-band patch/helix antenna arraysMITRE CORP·Filed 2002·Granted Apr 13, 2004·219 cites·51 claims
- 0291US6653987B1Dual-band quadrifilar helix antennaMITRE CORP·Filed 2002·Granted Nov 25, 2003·87 cites·35 claims
- 0385US11739089B2Acetamido-phenyltetrazole derivatives and methods of using the sameATHENEX INC·Filed 2021·Granted Aug 29, 2023·2 cites·23 claims
- 0481US10669236B2Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamideATHENEX HK INNOVATIVE LTD·Filed 2018·Granted Jun 2, 2020·1 cites·10 claims
- 0581US10450303B2Biaryl piperidine amide compounds and methods of use thereofATHENEX INC·Filed 2018·Granted Oct 22, 2019·3 cites·17 claims
- 0680US11230527B2Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n- benzylacetamideATHENEX HK INNOVATIVE LTD·Filed 2020·Granted Jan 25, 2022·1 cites·14 claims
- 0778US10899747B2Biaryl piperidine amide compounds and methods of use thereofATHENEX INC·Filed 2019·Granted Jan 26, 2021·1 cites·22 claims
- 0876US2025115555A1Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamideATNX SPV LLC·Filed 2024·Application pending·0 cites
- 0976US2025115589A1Polymorphisms of HM30181 MesylateHEALTH HOPE PHARMA LTD·Filed 2024·Application pending·0 cites
- 1073US12227494B2Polymorphisms of HM30181 mesylateATHENEX R&D LLC·Filed 2023·Granted Feb 18, 2025·0 cites·3 claims
- 1170US11739079B2Polymorphisms of HM30181 mesylateATHENEX R&D LLC·Filed 2021·Granted Aug 29, 2023·0 cites·2 claims
- 1269US10213435B2Biaryl compositions and methods for modulating a kinase cascadeATHENEX INC·Filed 2017·Granted Feb 26, 2019·1 cites·25 claims
- 1368US12215083B2Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamideATNX SPV LLC·Filed 2021·Granted Feb 4, 2025·0 cites·29 claims
- 1466US2023181566A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF ANGIOSARCOMAATHENEX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1565US2021347763A1Biaryl piperidine amide compounds and methods of use thereofATHENEX INC·Filed 2020·Application pending·0 cites
- 1662US2021196724A1Biaryl compositions and methods for modulating a kinase cascadeATHENEX INC·Filed 2021·Application pending·0 cites
- 1761US2024390360A1Therapeutic Combinations Of Orally Administered Paclitaxel, A P-gp Inhibitor, And A Checkpoint Inhibitor For The Treatment Of Solid TumorsATHENEX INC·Filed 2022·Application pending·0 cites
- 1859US10973828B2Biaryl compositions and methods for modulating a kinase cascadeATHENEX INC·Filed 2018·Granted Apr 13, 2021·0 cites·18 claims
- 1958US2019314361A1THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF ANGIOSARCOMAATHENEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2054US6856287B2Triple band GPS trap-loaded inverted L antenna arrayMITRE CORP·Filed 2003·Granted Feb 15, 2005·11 cites·13 claims
- 2150US2022106301A1Acetamido-phenylbenzamide derivatives and methods of using the sameATHENEX INC·Filed 2021·Application pending·0 cites
- 2248US2011038835A1Anilides and analogs as rho kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2008·Application pending·0 cites
- 2348US2011150833A1Benzopyrans and analogs as rho kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2008·Application pending·0 cites
- 2447US2011052562A1Benzimidazoles and analogs as rho kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →